Astellas Pharma Support for the Division of Urology
Left: Dr. Sender Herschorn receives a cheque from Mr. Michael Tremblay,
President of Astellas Canada Pharma Inc. |
|
The Division of Urology recently celebrated a generous
gift of $300,000 from Astellas Pharma Canada
Inc. in support of a research fellowship in Functional
Urology. This involves the study of developmental and
acquired disorders and reconstruction of the urinary
tract. The tremendous support received from industry
partners like Astellas, ensures that U of T leads the
way in cultivating and producing the next generation
of surgeons and world class researchers. Division and
Martin Barkin Chair in Urological Research Dr. Sender
Herschorn and Astellas President Michael Tremblay
say they look forward to continued cooperation in
urological research and other fields. Headquartered in
Markham, Ontario, Astellas is recognized as the first
Japanese pharmaceutical company in Canada. Involved
in clinical research and development as well as the
sales and marketing of products, Astellas focuses on
key therapeutic areas such as immunology, infectious
disease, cardiology, urology and dermatology.
Artur Cane with notes from Sender Herschorn
|